Evaluating Alcohol Use in Alcoholic Liver Disease

Part of paid clinical trials in New York, New York.

Sponsor
Nicole T Shen
Study ID
NCT03267069
Status
Recruiting
Apply to this trial

Conditions

  • Alcoholic Liver Disease

Eligibility Criteria

Sex
ALL
Age
18 Years - 80 Years
Healthy Volunteers
Not accepted

Interventions

  • survey — OTHER
    surveys will be administered at inclusion and follow-ups

Study Details

This prospective, analytic observational study will investigate alcohol recidivism in patients with alcoholic liver disease. All adult subjects presenting with alcoholic liver disease are considered for inclusion. Subjects able to give consent are included.

Key Dates

Start date
Nov 27, 2016
Status verified
Mar 2019
Primary completion
Nov 1, 2026
Completion
Nov 1, 2027

Study Design

Enrollment
160 participants (estimated)

Arms

  • Arm: alcohol liver disease
    Patients with alcohol liver disease consenting to participate in the study will be administered an initial survey at inclusion and then follow-up surveys at 3, 6, 9, 12, 15, and 18 month intervals and then 2, 5, and 10 years. There is no intervention cohort, all enrolled will complete the same surveys. Recidivism will be measured by responses to survey questions, clinical interviews documented in the chart, and urine ethnyl glucuronide or blood ethanol testing.

Primary Outcome Measure

alcohol recidivism assessed by questionnaire [ Time Frame: 6 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
New York Presbyterian Hospital - Weill Cornell Medicine and Columbia University Medical CenterNew YorkNew York10021
Nicole T Shen, MD
[email protected]
314-609-5911
Cecilia M Mero
[email protected]
(646) 962-9358

Find similar trials in New York, NY

By research site
New York Presbyterian Hospital - Weill Cornell Medicine and Columbia University Medical Center· New York, NY

Related Studies